These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 911241)

  • 41. Baclofen trial in six myotonic dystrophy patients.
    Guilleminault C; Flagg WH; Coburn SC; Dement WC
    Acta Neurol Scand; 1978 Mar; 57(3):232-8. PubMed ID: 352086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Baclofen treatment in chronic schizophrenia: a clinical trial.
    Bigelow LB; Nasrallah H; Carman J; Gillin JC; Wyatt RJ
    Am J Psychiatry; 1977 Mar; 134(3):318-20. PubMed ID: 320885
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical and laboratory assessment of the efficacy of baclofen (Lioresal) on urethral sphincter spasticity in patients with traumatic paraplegia.
    Hachen HJ; Krucker V
    Eur Urol; 1977; 3(4):237-40. PubMed ID: 913451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrathecal baclofen for spasticity in primary lateral sclerosis.
    Milano JB; Neto MC; Hunhevicz SC; Arruda WO; Ramina R; Barros E
    J Neurol; 2005 Jun; 252(6):740-1. PubMed ID: 15789133
    [No Abstract]   [Full Text] [Related]  

  • 45. Intrathecal baclofen in severe spasticity.
    McLean BN
    Br J Hosp Med; 1993 Feb 17-Mar 2; 49(4):262-7. PubMed ID: 8443626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-dose oral baclofen: experience in patients with multiple sclerosis.
    Smith CR; LaRocca NG; Giesser BS; Scheinberg LC
    Neurology; 1991 Nov; 41(11):1829-31. PubMed ID: 1944915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lioresal in the treatment of spasticity].
    Duma-Drzewińska A; Kiwerski J; Makowski J
    Pol Tyg Lek; 1976 Jul; 31(29):1259-62. PubMed ID: 948473
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
    Otero-Romero S; Sastre-Garriga J; Comi G; Hartung HP; Soelberg Sørensen P; Thompson AJ; Vermersch P; Gold R; Montalban X
    Mult Scler; 2016 Oct; 22(11):1386-1396. PubMed ID: 27207462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of intrathecal baclofen on muscle co-contraction in children with spasticity of cerebral origin.
    Sgouros S; Seri S
    Pediatr Neurosurg; 2002 Nov; 37(5):225-30. PubMed ID: 12411712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind trial with baclofen (Lioresal) and diazepam in spasticity due to multiple sclerosis.
    From A; Heltberg A
    Acta Neurol Scand; 1975 Feb; 51(2):158-66. PubMed ID: 1090103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Baclofen pump intervention for spasticity affecting pulmonary function.
    Britton D; Goldstein B; Jones-Redmond J; Esselman P
    J Spinal Cord Med; 2005; 28(4):343-7. PubMed ID: 16396387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacological treatment of pathological increases in muscle tonus].
    Reisner H
    Wien Med Wochenschr; 1978 Feb; 128(3):57-62. PubMed ID: 625998
    [No Abstract]   [Full Text] [Related]  

  • 53. Baclofen in the treatment of cerebral palsy.
    Albright AL
    J Child Neurol; 1996 Mar; 11(2):77-83. PubMed ID: 8881981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pharmacological management of spasticity.
    Saulino M; Jacobs BW
    J Neurosci Nurs; 2006 Dec; 38(6):456-9. PubMed ID: 17233517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracranial fat embolization due to baclofen pump.
    Qian Y; Ances BM; Pruitt A; Choi B; Moonis G
    Neurology; 2005 Mar; 64(5):919. PubMed ID: 15753440
    [No Abstract]   [Full Text] [Related]  

  • 56. [Pharmacological treatment of spasticity in multiple sclerosis].
    Heinzlef O; Monteil-Roch I
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S62-8. PubMed ID: 22721367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacology of spasticity.
    Davidoff RA
    Neurology; 1978 Sep; 28(9 Pt 2):46-51. PubMed ID: 30921
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical outcome and complications of intrathecal baclofen pump in multiple sclerosis patients: a retrospective study.
    Khan AA; Birks-Agnew I; Bullock P; Rushton D
    NeuroRehabilitation; 2010; 27(2):117-20. PubMed ID: 20871140
    [No Abstract]   [Full Text] [Related]  

  • 59. Is the antispastic action of baclofen mediated by GABAB receptors? GABAB receptors and spasticity.
    Wüllner U; Klockgether T
    Trends Pharmacol Sci; 1990 Mar; 11(3):103. PubMed ID: 1966568
    [No Abstract]   [Full Text] [Related]  

  • 60. Intrathecal fentanyl alleviates spasticity in the presence of tolerance to intrathecal baclofen.
    Chabal C; Jacobson L; Terman G
    Anesthesiology; 1992 Feb; 76(2):312-4. PubMed ID: 1736707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.